FGF23 and chronic kidney disease: Recent evidence has suggested that serum circulating molecules are involved in the regulation of mineral metabolism and ectopic calcification processes, including MGP, fetuin-A, FGF-23/klotho, PPi, and sclerostin, are favorable diagnostic biomarkers for VC in patients with CKD [19, 160].